Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

Guías ESC-EAS 2025 para Dislipidemias | Podcast Cardiología Sanofi

Descubre los episodios más recientes de "Desglosando la actualidad", el espacio de análisis y conocimiento desarrollado en el marco del XXXI Congreso Colombiano de Cardiología y Cirugía Cardiovascular. Una iniciativa que promueve el aprendizaje continuo y el intercambio de experiencias entre profesionales de la salud cardiovascular, abordando los temas más relevantes y actuales del campo cardiológico.

Brochure maladie fabry pediatrie

Patient-Reported Outcome Measures (PROMs) in Dermatology

Interview by DermTalks
DermTalks is a project led with a board of dermatologists and intended to address current challenges, data gaps and emerging trends in dermatology across North-European countries.

Speaker: Prof. Mette Deleuran, Associate Professor and Chair of the Department of Dermatology and Venereology, Aarhus University Hospital, Denmark.

Education and Psychosocial Support After T1D Diagnosis – ATTD 2026

The video discusses the management of patient anxiety after positive T1D islet autoantibody results: Guidance on monitoring, education, and psychosocial support. 

Technology Advances and the Persistent Burden of T1D – ATTD 2026

The video discusses how advances in insulin delivery have yet to translate into improved population-level glycemic outcomes

The Growing Global Burden of T1D

The video discusses the rising T1D burden: Adult-onset misclassification, familial risk, and autoimmune comorbidities impacting diagnosis and management. 

From Registry to Reality: Reduced Stroke Incidence with Agalsidase Beta in Fabry Disease

From Registry to Reality: Reduced Stroke Incidence with Agalsidase Beta in Fabry Disease

From Registry to Reality: Reduced Stroke Incidence with Agalsidase Beta in Fabry Disease

From Registry to Reality: Reduced Stroke Incidence with Agalsidase Beta in Fabry Disease

Tolerability of Accelerated Agalsidase Beta Infusions in Fabry Disease: The SHORTEN Study Analysis

Tolerability of Accelerated Agalsidase Beta Infusions in Fabry Disease: The SHORTEN Study Analysis